Search by Drug Name or NDC

NDC 65862-0244-30 Atomoxetine 100 mg/1 Details

Atomoxetine 100 mg/1

Atomoxetine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is ATOMOXETINE HYDROCHLORIDE.

MedlinePlus Drug Summary

Atomoxetine is used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children and adults with ADHD. Atomoxetine is in a class of medications called selective norepinephrine reuptake inhibitors. It works by increasing the levels of norepinephrine, a natural substance in the brain that is needed to control behavior.

Related Packages: 65862-0244-30
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Atomoxetine

Product Information

NDC	65862-0244
Product ID	65862-244_4675a097-a29b-4d3a-bc77-8e41cd5925d1
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Atomoxetine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Atomoxetine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE
Route	ORAL
Active Ingredient Strength	100
Active Ingredient Units	mg/1
Substance Name	ATOMOXETINE HYDROCHLORIDE
Labeler Name	Aurobindo Pharma Limited
Pharmaceutical Class	Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA079016
Listing Certified Through	2024-12-31

Package

NDC 65862-0244-30 (65862024430)

Pricing Information	N/A
NDC Package Code	65862-244-30
Billing NDC	65862024430
Package	30 CAPSULE in 1 BOTTLE (65862-244-30)
Marketing Start Date	2017-05-30
NDC Exclude Flag	N